Fig. 2
a-c: MK features of CCRCC a, AML b and RO c, respectively. A significant higher value was shown in AML (1.32 ± 0.16) than the rest renal tumors (0.81 ± 0.08 for RO, 0.43 ± 0.08 for CCRCC, P < 0.05)
Fig. 2 | Cancer Imaging
a-c: MK features of CCRCC a, AML b and RO c, respectively. A significant higher value was shown in AML (1.32 ± 0.16) than the rest renal tumors (0.81 ± 0.08 for RO, 0.43 ± 0.08 for CCRCC, P < 0.05)